73 related articles for article (PubMed ID: 400682)
1. Culture characteristics of human granulocyte-macrophage progenitor cells and their regulation in the context of bone marrow transplantation.
Broxmeyer HE
Exp Hematol; 1979; 7 Suppl 5():149-58. PubMed ID: 400682
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
3. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
[TBL] [Abstract][Full Text] [Related]
5. Production of colony-stimulating factor(s) for granulocyte-macrophage and multipotential (granulocyte/erythroid/megakaryocyte/macrophage) hematopoietic progenitor cells (CFU-GEMM) by clonal lines of human IL-2-dependent T-lymphocytes.
Greenberger JS; Krensky AM; Messner H; Burakoff SJ; Wandl U; Sakakeeny MA
Exp Hematol; 1984 Oct; 12(9):720-7. PubMed ID: 6333354
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-E-mediated modulation of human marrow CFU-GM Ia-antigen expression: kinetics and specificity.
Pelus LM
Exp Hematol; 1984 Dec; 12(11):831-7. PubMed ID: 6210207
[TBL] [Abstract][Full Text] [Related]
7. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
[TBL] [Abstract][Full Text] [Related]
8. Detection of murine bone marrow granulocyte/macrophage progenitor cells (GM-CFU) in serum-free cultures stimulated with purified M-CSF or GM-CSF.
Merchav S; Wagemaker G
Int J Cell Cloning; 1984 Nov; 2(6):356-67. PubMed ID: 6335156
[TBL] [Abstract][Full Text] [Related]
9. [Granulocyte-macrophage progenitor cells in allogenic bone marrow transplantation: correlation of progenitor cell content and regeneration in the graft].
Gidáli J; Poros A; Harsányi V; Fehér I; Mód A; Hollán Z
Orv Hetil; 1989 Oct; 130(42):2251-4, 2257. PubMed ID: 2812758
[TBL] [Abstract][Full Text] [Related]
10. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
[TBL] [Abstract][Full Text] [Related]
11. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
Tennant GB; Jacobs A; Bailey-Wood R
Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
[TBL] [Abstract][Full Text] [Related]
13. Different Ia antigen characterization between granulocyte progenitor cells (CFC-G) and monocyte-macrophage progenitor cells (CFC-M).
Numata M; Koizumi S; Horita S; Ueno Y; Yamagami M; Taniguchi N
Exp Hematol; 1985 Sep; 13(8):827-32. PubMed ID: 3862598
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of mouse granulocytes and macrophages produced in vitro from bone marrow progenitors stimulated with interleukin 3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF).
Bender JG; Unverzagt KL; Maples PB; Mehrotra Y; Mellon J; Van Epps DE; Stewart CC
Exp Hematol; 1992 Oct; 20(9):1135-40. PubMed ID: 1361455
[TBL] [Abstract][Full Text] [Related]
15. Purification of murine bone-marrow-derived granulocyte-macrophage colony-forming cells.
Williams DE; Straneva JE; Shen RN; Broxmeyer HE
Exp Hematol; 1987 Mar; 15(3):243-50. PubMed ID: 3817051
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
17. The CD34+ cell fraction in bone marrow and blood is not universally predictive of CFU-GM.
Janssen WE; Farmelo MJ; Lee C; Smilee R; Kronish L; Elfenbein GJ
Exp Hematol; 1992 May; 20(4):528-30. PubMed ID: 1373692
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
19. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
20. Survival of human granulocyte-macrophage progenitor cells (CFU-C) after cryopreservation as a function of the time of storage.
Grilli G; Rüber E; Baur G; Fliedner TM
Haematologica; 1982 Aug; 67(4):517-21. PubMed ID: 6815011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
